In vitro antisense therapeutics for a deep intronic mutation causing Neurofibromatosis type 2
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
In vitro antisense therapeutics for a deep intronic mutation causing Neurofibromatosis type 2
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF HUMAN GENETICS
Volume 21, Issue 7, Pages 769-773
Publisher
Springer Nature America, Inc
Online
2012-11-28
DOI
10.1038/ejhg.2012.261
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Peripheral Administration of Antisense Oligonucleotides Targeting the Amyloid-β Protein Precursor Reverses AβPP and LRP-1 Overexpression in the Aged SAMP8 Mouse Brain
- (2018) Michelle A. Erickson et al. JOURNAL OF ALZHEIMERS DISEASE
- Splice Modulating Therapies for Human Disease
- (2012) Pietro Spitali et al. CELL
- Sustained Therapeutic Reversal of Huntington's Disease by Transient Repression of Huntingtin Synthesis
- (2012) Holly B. Kordasiewicz et al. NEURON
- Genetic testing and screening of individuals at risk of NF2
- (2011) DG Evans et al. CLINICAL GENETICS
- Effects of splicing mutations on NF2-transcripts: Transcript analysis and information theoretic predictions
- (2011) James R. Ellis et al. GENES CHROMOSOMES & CANCER
- Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model
- (2011) Yimin Hua et al. NATURE
- Targeting RNA to treat neuromuscular disease
- (2011) Francesco Muntoni et al. NATURE REVIEWS DRUG DISCOVERY
- Antisense Oligonucleotides Delivered to the Mouse CNS Ameliorate Symptoms of Severe Spinal Muscular Atrophy
- (2011) M. A. Passini et al. Science Translational Medicine
- New insights in gene-derived therapy: the example of Duchenne muscular dystrophy
- (2010) Annemieke Aartsma-Rus et al. Annals of the New York Academy of Sciences
- Genes, mutations, and human inherited disease at the dawn of the age of personalized genomics
- (2010) David N. Cooper et al. HUMAN MUTATION
- Further genotype â phenotype correlations in neurofibromatosis 2
- (2009) SK Selvanathan et al. CLINICAL GENETICS
- Antisense therapeutics for neurofibromatosis type 1 caused by deep intronic mutations
- (2009) Eva Pros et al. HUMAN MUTATION
- Neurofibromatosis type 2
- (2009) Ashok R Asthagiri et al. LANCET
- Gene Knockdowns in Adult Animals: PPMOs and Vivo-Morpholinos
- (2009) Jon Moulton et al. MOLECULES
- Neurofibromatosis type 2 (NF2): A clinical and molecular review
- (2009) D Gareth R Evans Orphanet Journal of Rare Diseases
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started